Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2013 Nov 27;2(6):e000424.
doi: 10.1161/JAHA.113.000424.

Safety of percutaneous patent ductus arteriosus closure: an unselected multicenter population experience

Affiliations
Comparative Study

Safety of percutaneous patent ductus arteriosus closure: an unselected multicenter population experience

Howaida G El-Said et al. J Am Heart Assoc. .

Abstract

Background: The technique and safety of transcatheter patent ductus arteriosus (PDA) closure have evolved during the past 20 years. We sought to report a multicenter experience of PDA closure with a focus on the rate of adverse events (AE) and a review of institutional practice differences.

Methods and results: Outcome data on transcatheter PDA closure were collected at 8 centers prospectively using a multicenter registry (Congenital Cardiac Catheterization Project on Outcome Registry). Between February 2007 and June 2010, 496 PDA closures were recorded using a device in 338 (68%) or coils in 158 (32%). Most patients had an isolated PDA (90%). Fifty percent of patients were between 6 months and 3 years old, with only 40 patients (8%) <6 months old. Median minimum PDA diameter was 2.5 mm (range 1 to 12 mm; IQR 2 to 3 mm) for device closure and 1 mm (range 0.5 to 6 mm; IQR 1 to 2 mm) for coil closure (P<0.001). A device rather than coil was used in patients <3 years, weight <11 kg, and with a PDA minimum diameter >2 mm (all P<0.001). Three of 8 centers exclusively used a device for PDAs with a diameter >1.5 mm. In 9% of cases (n=46), an AE occurred; however, only 11 (2%) were classified as high severity. Younger age was associated with a higher AE rate. Coil-related AEs were more common than device-related AEs (10% versus 2%, P<0.001).

Conclusions: PDA closure in the present era has a very low rate of complications, although these are higher in younger children. Technical intervention-related events were more common in coil procedures compared with device procedures. For PDAs ≤2.5 mm in diameter, institutional differences in preference for device versus coil exist.

Keywords: PDA; adverse events; complications; interventional catheterization; safety.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Proportion of 2 PDA closure methods (coils vs devices) based on PDA internal diameter. PDA indicates patent ductus arteriosus.
Figure 2.
Figure 2.
Average annual PDA cases for each institution. Shaded bars represent the average annual PDA cases, and strippled bars represent the PDA percentage of total cases. PDA indicates patent ductus arteriosus.
Figure 3.
Figure 3.
Differences in the preferred PDA closure method (coils vs devices) based on PDA internal diameter in 8 institutions. Figure shows median minimum diameter, IQR, and range by device or coil for each institution. IQR indicates interquartile range; PDA, patent ductus arteriosus.
Figure 4.
Figure 4.
Adverse event (AE) rates by institution shown as any event and subdivided showing rates of higher severity level 3 or 4 events.

References

    1. Tometzki AJ, Arnold R, Peart I, Sreeram N, Abdulhamed JM, Godman MJ, Patel RG, Kitchiner DJ, Bu'Lock FA, Walsh KP. Transcatheter occlusion of the patent ductus arteriosus with Cook detachable coils. Heart. 1996; 76:531-534 - PMC - PubMed
    1. Faella HJ, Hijazi ZM. Closure of the patent ductus arteriosus with the Amplatzer PDA device: immediate results of the international clinical trial. Catheter Cardiovasc Interv. 2000; 51:50-54 - PubMed
    1. Pass RH, Hijazi Z, Hsu DT, Lewis V, Hellenbrand WE. Multicenter USA Amplatzer patent ductus arteriosus occlusion device trail: initial and one‐year results. J Am Coll Cardiol. 2004; 44:513-519 - PubMed
    1. Jang GY, Son CS, Lee JW, Lee JY, Kim SJ. Complications after transcatheter closure of patent ductus arteriosus. J Korean Med Sci. 2007; 12:484-490 - PMC - PubMed
    1. Bergersen L, Gauvreau K, Jenkins KJ, Lock JE. Adverse event rates in congenital cardiac catheterization: a new understanding of risks. Congenit Heart Dis. 2008; 3:90-105 - PubMed

Publication types

MeSH terms